Fasting insulin is indicative of insulin demand and is used to calculate HOMA-IR
some people notice changes after a few sessions, while others may take longer
Moreover, combination therapies have demonstrated significant advantages, such as Novo Nordisks CagriSema (semaglutide + cagrilintide), which shows superior glycemic control and weight reduction effects compared to semaglutide alone, demonstrating that combination therapy can achieve more than the sum of its parts while reducing side effects
Tirzepatide, a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management, has generated interest for addressing metabolic complications in thyroid patients
When Could It Be Available
Ideal candidates for semaglutide injections are overweight or obese adult patients with one or more weight-related conditions who are seeking weight loss in order to achieve their health and weight goals at a fast yet safe pace
